Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Cancer Res. 2017 Apr 5;77(14):3951–3960. doi: 10.1158/0008-5472.CAN-16-3322

Figure 1. Odds ratios (95% CI) for EOC for doubling of androgen concentrations and EOC risk by the Type I and Type II classification: the Ovarian Cancer Cohort Consortium (OC3).

Figure 1

Results were derived from conditional logistic regression models, additionally adjusted for OC use (never/ever/missing) and parity (never/ever/missing). Pair-wise heterogeneity tests were performed, using the likelihood ratio test comparing models assuming (1) the same association between exposure and outcomes compared to (2) a model assuming different associations for each subtype. DHEAS=dehydroepiandrosterone sulfate; SHBG=sex hormone binding globulin